DVL3 and neoplasm: However, there was no significant association between DVL3 expression and other clinical parameters, such as tumor stages (P = 0.369), grading (P = 0.658), metastasis (P = 0.243), β-catenin (P = 0.009) and CyclinD1 (P = 0.009).